Rothschild & CO Asset Management Us Inc. Aclaris Therapeutics, Inc. Transaction History

Rothschild & CO Asset Management Us Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 08, 2019	SELL	$5.63 - $7.84 $473,184 - $658,928	-84,047 Closed	0 $0
Q4 2018 Feb 05, 2019	BUY	$6.3 - $15.4 $222,068 - $542,834	35,249 Added 72.23%	84,047 $621,000
Q3 2018 Nov 13, 2018	SELL	$14.38 - $20.89 $8,541 - $12,408	-594 Reduced 1.2%	48,798 $709,000
Q2 2018 Aug 07, 2018	BUY	$16.46 - $20.33 $122,561 - $151,377	7,446 Added 17.75%	49,392 $986,000
Q1 2018 May 08, 2018	SELL	$17.08 - $25.64 $74,178 - $111,354	-4,343 Reduced 9.38%	41,946 $735,000
Q4 2017 Feb 12, 2018	SELL	$21.47 - $27.8 $75,016 - $97,133	-3,494 Reduced 7.02%	46,289 $1.14 Million
Q3 2017 Nov 08, 2017	BUY	$23.02 - $28.8 $1.15 Million - $1.43 Million	49,783	49,783 $1.29 Million

87.6M

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $124M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Rothschild & CO Asset Management Us Inc., based on Form 13F filings with the SEC.

Stay updated on Rothschild & CO Asset Management Us Inc. with notifications on news.